Scientists have identified a new, highly conserved molecular target on the influenza A virus and demonstrated that human antibodies against this target are protective in animal models of seasonal and ....
The US Food and Drug Administration (FDA) has approved Zortress (everolimus) oral tablets for the prevention of organ rejection of kidney transplants in adult patients at low-to-moderate immunologic risk. ....
Roche and OSI Pharmaceuticals have gained US Food and Drug Administration (FDA) approval for the use of Tarceva as a maintenance treatment for non-small cell lung cancer. The FDA's decision comes despite ....
China, Taiwan and South Korea represent endemic areas for viral hepatitis, with prevalence rates ranging from 4-13 percent for Hepatitis B (HBV) and from 1-4 percent for Hepatitis C (HCV). While there ....
Elga, the global labwater brand of Veolia Water Solutions & Technologies has introduced a Type II (Electrodeionisation) EDI water purification system. The Purelab Pulse has been developed to produce consistently ....
The third annual Bio/Pharmaceutical Cold Chain Management Asia conference was held from May 12-13 in Sentosa, Singapore. The event addressed the logistics challenges and issues that are faced by pharma ....
The European Commission (EC) has granted Diovan (valsartan) a pediatric indication for the treatment of hypertension in children and adolescents 6-18 years of age. Following the Commission's decision, ....
The HealthLinx OvPlex ovarian cancer diagnostic will be released in Singapore in July. Inex has the rights to distribute the diagnostic in Singapore, Thailand, Vietnam, Malaysia, Indonesia and India. ....
DHL has seen a record number of movements of healthcare products in 2009 in Asia. Compared to 2008, shipment of finished pharmaceuticals, vaccines, medical equipment and devices and clinical trials facilitated ....
With US$110 billion in global sales exposed to generic competition for the top 50 pharmaceutical companies through to 2014, branded pharma must look to emerging markets, biologics and continued cost-saving ....